Trademark Attorney / Law Firm

Ryan Fillmore – Trademark Portfolio

Ryan Fillmore has 3 trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 3 trademarks are successfully registered — a 100% registration rate. The strongest areas of practice include Class 37 (Building & Construction) and Class 44 (Medical Services). Filing activity has been recorded from 2019 through 2024, spanning 2 years.

3 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

Ryan Fillmore's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

37
Building & Construction (1 filing)

Building construction; repair; installation services

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademark applications has Ryan Fillmore filed?

Ryan Fillmore has filed 3 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 3 registered.

What trademark classes does Ryan Fillmore specialize in?

Ryan Fillmore has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 37 (Building & Construction), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 37 covers building construction; repair; installation services.

How long has Ryan Fillmore been filing trademarks?

Ryan Fillmore's trademark filing history with the USPTO spans from 2019 to 2024, covering 5 years of trademark practice. During this period, Ryan Fillmore has handled 3 trademark applications.

What is Ryan Fillmore's trademark registration success rate?

Ryan Fillmore has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.